Literature DB >> 16839401

Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility.

N Hizawa1, Y Maeda, S Konno, Y Fukui, D Takahashi, M Nishimura.   

Abstract

BACKGROUND: We previously detected a promoter polymorphism (- 109C/T) in the gene for the beta-chain of the high-affinity receptor for IgE (FCER1B), which was associated with total serum IgE levels but not with asthma in a Japanese population. A genetic interaction is biologically plausible between FcepsilonRI-beta and the plasminogen activator inhibitor 1 (PAI-1), which is highly expressed in mast cells in asthmatics and plays an essential role in airway remodelling. We hypothesized that FCER1B promoter polymorphisms, by modifying the intensity of mast cell activation signals, modulate the genetic effects of a functional 4G/5G polymorphism in the PAI-1 gene on asthma. OBJECTICIVE: To examine whether FCER1B promoter polymorphisms (- 109C/T and - 654C/T) influence the genetic effects of the functional polymorphism (4G/5G) at the PAI-1 promoter region on asthma susceptibility using a case-control analysis.
METHODS: Subjects (374 asthmatic patients and 374 non-asthmatic controls) were divided into combined genotype groups based on the presence of FCER1B - 109TT and - 654CC genotypes and the PAI-1 4G allele. Logistic regression analysis was used to estimate adjusted odds ratios for asthma associated with the different genotype groups.
RESULTS: Individuals homozygous for the FCER1B - 109T/ - 654C haplotype and the PAI - 1 5G allele had a reduced susceptibility to asthma; the odds ratio for the development of asthma was 0.20 (95% confidence interval, 0.084 - 0.46; P = 0.00015) for them, compared with individuals also homozygous for the - 109T/- 654C haplotype at FCER1B but carrying the 4G allele at PAI-1. The regression model also showed an interaction of the PAI-1 4G/5G genotype with the FCER1B-109C/T (P for interaction = 0.0017) or FCER1B-654C/T (P for interaction = 0.031) on asthma.
CONCLUSION: The present findings suggest a synergistic interaction between FCER1B and PAI-1 genes in asthma susceptibility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16839401     DOI: 10.1111/j.1365-2222.2006.02413.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  16 in total

Review 1.  Functional and clinical consequences of Fc receptor polymorphic and copy number variants.

Authors:  S Bournazos; J M Woof; S P Hart; I Dransfield
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

2.  Exploiting cellular-developmental evolution as the scientific basis for preventive medicine.

Authors:  J S Torday; V K Rehan
Journal:  Med Hypotheses       Date:  2009-01-14       Impact factor: 1.538

3.  Association Between Serum IgE Levels and the CTLA4 +49A/G and FCER1B -654C/T Polymorphisms in Korean Children With Asthma.

Authors:  Kyu-Young Oh; Mi-Jin Kang; Won-Ah Choi; Ji-Won Kwon; Byoung-Ju Kim; Jinho Yu; Soo-Jong Hong
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

4.  Involvement of Fc(epsilon)R1beta gene polymorphisms in susceptibility to atopy in Korean children with asthma.

Authors:  Eun Soo Kim; Seung-Hyun Kim; Kyung Won Kim; Hae-Sim Park; Eun Soon Shin; Jong Eun Lee; Myung Hyun Sohn; Kyu-Earn Kim
Journal:  Eur J Pediatr       Date:  2009-03-14       Impact factor: 3.183

5.  Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids.

Authors:  Prescott G Woodruff; Homer A Boushey; Gregory M Dolganov; Chris S Barker; Yee Hwa Yang; Samantha Donnelly; Almut Ellwanger; Sukhvinder S Sidhu; Trang P Dao-Pick; Carlos Pantoja; David J Erle; Keith R Yamamoto; John V Fahy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-26       Impact factor: 11.205

Review 6.  Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.

Authors:  Rui-Ming Liu
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

Review 7.  Genetics of food allergy.

Authors:  Xiumei Hong; Hui-Ju Tsai; Xiaobin Wang
Journal:  Curr Opin Pediatr       Date:  2009-12       Impact factor: 2.856

8.  FCεRI gene promoter polymorphisms and total IgE levels in susceptibility to atopic dermatitis in Korea.

Authors:  Kui Young Park; Mi Kyung Park; Eun Joo Kim; Mi-Kyung Lee; Seong Jun Seo
Journal:  J Korean Med Sci       Date:  2011-06-20       Impact factor: 2.153

9.  The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.

Authors:  Wei Nie; Bing Li; Qing-Yu Xiu
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

10.  Increased mortality in septic shock with the 4G/4G genotype of plasminogen activator inhibitor 1 in patients of white descent.

Authors:  Gloria García-Segarra; Gerard Espinosa; Dolors Tassies; Josep Oriola; Jesús Aibar; Albert Bové; Pedro Castro; Joan-Carles Reverter; Josep-Maria Nicolás
Journal:  Intensive Care Med       Date:  2007-05-31       Impact factor: 41.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.